Ischaemic heart disease is a leading cause of morbidity and mortality in both women and
men. Compared with men, symptomatic women who are suspected of having myocardial …

Women exhibit a greater symptom burden, more functional disability, and a higher
prevalence of no obstructive coronary artery disease compared to men when evaluated for …

Cardiovascular disease is the leading cause of death worldwide. In the presence of signs
and symptoms of myocardial ischaemia, women are more likely than men to have no …

Background—Coronary microvascular dysfunction (CMD) is a prevalent and prognostically
important finding in patients with symptoms suggestive of coronary artery disease. The …

Background: Currently as many as one-half of women with suspected myocardial ischemia
have no obstructive coronary artery disease (CAD), and abnormal coronary reactivity (CR) is …

Recognition of ischemic heart disease (IHD) is often delayed or deferred in women. Thus,
many at risk for adverse outcomes are not provided specific diagnostic, preventive, and/or …

Evolving knowledge regarding sex differences in coronary heart disease is emerging. Given
the lower burden of obstructive coronary artery disease (CAD) and preserved systolic …

Cardiovascular disease remains the leading cause of morbidity and mortality for both
women and men. Emerging evidence supports that ischemic heart disease (IHD) may …

Ischemic heart disease (IHD) is the leading cause of mortality in women. While traditional
cardiovascular risk factors play an important role in the development of IHD in women …

Background—Coronary vascular dysfunction has been linked to atherosclerosis and
adverse cardiovascular outcomes in men, but these relationships have not been firmly …